TransCode and BRAIN to Co-develop CRISPR-derived Technology Platform for Oncology
TransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreTransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreStemBioSys, Inc. (StemBioSys) announced on Monday, the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that is developed to enable the
Read moreEctica Technologies and SCREEN Holdings will be exhibiting together at the PREDiCT 7th Annual 3D TISSUE MODELS SUMMIT taking place
Read moreAmerican biotech Oragenics, Inc. announced on Thursday the posting of a preprint manuscript in bioRxiv (pronounced “bio-archives”) evaluating a novel
Read moreThe groundbreaking kit Clickable 19F NMR Probes, developed by CF Plus Chemicals, includes a variety of 9 fluorinated azides that
Read moreThe unique kit Fluoroalkyl Azide Solutions developed by CF Plus Chemicals unlocks new fluorinated chemical space as it opens facile
Read moreThe novel 3DProSeed ® StromaLine ® developed by Ectica is an advantageous collection of pre-developed and well characterized stromal models
Read moreGoogle’s parent company Alphabet Inc has announced the launch of a new UK-based company called Isomorphic Labs, dedicated to applying
Read moreThe first two projects funded within the translational BRIDGE beLAB1407 collaboration will focus on new mechanisms to treat cancer, Evotec
Read moreBoehringer Ingelheim and Twist Bioscience have entered into a research collaboration that covers multiple antibody research programs. Twist Bioscience Corporation,
Read more